Organon & Co | OGN - Attività Correnti





Attività Correnti Cambiamento Data
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Celltrion KRW 493.66B 12.09B 2026-06
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 856.04M 41.5M 2026-09
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Gilead Sciences USD 16.55B 4.02B 2026-09
Glaxosmithkline GBP 17.9B 134M 2026-09
Kangmei Pharma CNY 6.66B 143.43M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Merck USD 38.94B 2.26B 2026-09
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Novartis USD 28.75B 2.14B 2026-09
Organigram Holdings CAD 280.09M 30M 2026-06
Organon & Co USD 5.37B 258M 2026-09
Ovoca Bio EUR 2.07M 510K 2025-12
Pharma Mar EUR 295.56M 14.62M 2026-09
Qiagen NV USD 1.66B 116.37M 2026-06
Sartorius EUR 1.65B 8.4M 2026-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tilray USD 729.32M 28.18M 2025-09
Zealand Pharma A/S 15.02B 652.12M 2026-03